StockClub

GENPF

GENPFGenix Pharmaceuticals Corporation$ --
Genix Pharmaceuticals Corporation

Genix Pharmaceuticals Corporation

GENPF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 10/31/2025FY2025 Q4
Revenue
0M CAD
YoY -100.0%
Operating Income
-0M CAD
YoY +66.0%
Net Income
-0M CAD
YoY -159.9%
EPS
-0CAD
YoY -157.7%

Revenue

CAD0
FY2024 Q1CAD71
CAD71
Q1
FY2024 Q2CAD2,984
CAD2,984
Q2
FY2024 Q3CAD3,983
CAD3,983
Q3
FY2024 Q4CAD4,051
CAD4,051
Q4
FY2025 Q1CAD0
CAD0
Q1
FY2025 Q2CAD0
CAD0
Q2
FY2025 Q3CAD0
CAD0
Q3
FY2025 Q4CAD0
CAD0
Q4
Actual
CAD-4,051 (-100.0%)

Net Income

CAD-311,809
FY2024 Q1CAD-59,058
CAD-59,058
Q1
FY2024 Q2CAD-145,001
CAD-145,001
Q2
FY2024 Q3CAD-227,173
CAD-227,173
Q3
FY2024 Q4CAD-73,196
CAD-73,196
Q4
FY2025 Q1CAD-107,254
CAD-107,254
Q1
FY2025 Q2CAD-159,234
CAD-159,234
Q2
FY2025 Q3CAD-219,503
CAD-219,503
Q3
FY2025 Q4CAD-311,809
CAD-311,809
Q4
Actual
CAD-238,613 (-326.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:CAD0
FY2020
CAD0
FY2021
Actual:CAD0
FY2021
CAD0
FY2022
Actual:CAD0
FY2022
CAD0
FY2023
Actual:CAD12,347
FY2023
CAD12,347
FY2024
Actual:CAD4,051
FY2024
CAD4,051
FY2025
Actual:CAD0
FY2025
CAD0

Analyst Estimates

No forecast data